Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea Corylifolia in the forced swimming test in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 2, 2008, Pages 510-519

  Yi, Li Tao ^a   Li, Yu Cheng ^a   Pan, Ying ^a   Li, Jian Mei ^a   Xu, Qun ^a   Mo, Shi Fu ^a,c   Qiao, Chun Feng ^c   Jiang, Fu Xin ^a   Xu, Hong Xi ^c   Lu, Xiao Bo ^b   Kong, Ling Dong ^a,b   Kung, Hsiang Fu ^b  

^a NANJING UNIVERSITY   (China)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Forced swimming test; Hypothalamic pituitary adrenal axis; Monoamine neurotransmitter system; Psoralidin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTIDEPRESSANT AGENT; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; NEUROTRANSMITTER; PSORALEA CORYLIFOLIA EXTRACT; PSORALIDIN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CLIMBING; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; FORCED SWIMMING TEST; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PLANT SEED;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BENZOFURANS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; COUMARINS; EXPLORATORY BEHAVIOR; HYDROXYINDOLEACETIC ACID; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMOBILITY RESPONSE, TONIC; MALE; MICE; MICE, INBRED ICR; MODELS, ANIMAL; MOTOR ACTIVITY; PITUITARY-ADRENAL SYSTEM; PREFRONTAL CORTEX; PSORALEA; SEEDS; SEROTONIN; SWIMMING; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION;

EID: 38849123655     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.10.005     Document Type: Article

References (57)

1. Andrea F.M., Mario F.J., Carmine M.P., Audrey R., Tyrka L.H.P., Linda L.C., et al. Depression and stress: is there an endophenotype?. Rev Bras Psiquiatr 29 (2007) 13-18
2. Archer J. Tests for emotionality in rats and mice: a review. Anim Behav 21 (1973) 205-235
3. Aubry J.M., Pozzoli G., and Vale W.W. Chronic treatment with the antidepressant amitriptyline decreases CRF-R1receptor mRNA levels in the rat amygdala. Neurosci Lett 266 (1999) 197-200
4. Barden N., Reul J.M., and Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?. Trends Neurosci 18 (1995) 6-11
5. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology (Berl) 94 (1988) 147-160
6. Bundgaard C., Larsen F., Jorgensen M., and Gabrielsson J. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels. Eur J Pharm Sci 29 (2006) 394-404
7. Caldarone B.J., Karthigeyan K., Harrist A., Hunsberger J.G., Wittmack E., King S.L., et al. Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice. Psychopharmacology (Berl) 170 (2003) 94-101
8. Chen Y., Kong L.D., Xia X., Kung H.F., and Zhang L. Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the forced swimming test in mice. J Ethnopharmacol 96 (2005) 451-459
9. Chino M., Sato K., Yamazaki T., and Maitani T. Constituent of natural food additive hokosshi extract and an analytical method for the additive in foods. Shokuhin Eiseigaku Zasshi 43 (2002) 352-355
10. Clarke A.S., Kraemer G.W., and Kupfer A.J. Effects of rearing condition on HPA axis response to fluoxetine and desipramine treatment over repeated social separations in young rhesus monkeys. Psychiatry Res 79 (1998) 91-104
11. Connor T.J., Kelly J.P., and Leonard B.E. Forced swim test-induced neurochemical, endocrine and immune changes in the rat. Pharmacol Biochem Behav 58 (1997) 961-968
12. Connor T.J., Kelliher P., Shen Y., Harkin A., Kelly J.P., and Leonard B.E. Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacol Biochem Behav 65 (2000) 591-597
13. Cryan J.F., and Lucki I. Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine (2C) receptors. J Pharmacol Exp Ther 295 3 (2000) 1120-1126
14. Cryan J., Valentino R., and Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modifying rats forced swimming test. Neurosci Biobehav Rev 29 (2005) 547-569
15. Curzon G., and Green A.R. Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol 39 (1970) 653-655
16. Damjanoska K.J., Van de Kar L.D., Kindel G.H., Zhang Y., D'Souza D.N., Garcia F., et al. Chronic fluoxetine differentially affects 5-Hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus. J Pharmacol Exp Ther 306 (2003) 563-571
17. De Groote L., Peñalva R.G., Flachskamm C., Reul J.M., and Linthorst A.C. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists. J Neurochem 94 (2005) 45-56
18. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121 (1995) 66-72
19. Deuschle M., Hamann B., Meichel C., Krumm B., Lederbogen F., Kniest A., et al. Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. J Clin Psychopharmacol 23 (2003) 201-205
20. Drossopoulou G., Antoniou K., Kitraki E., Papathanasiou G., Papalexi E., Dalla C., et al. Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience 126 (2004) 849-857
21. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 54 (1997) 597-606
22. Duncan G.E., Knapp D.J., Carson S.W., and Breese G.R. Differential effects of chronic antidepressant treatment on swim stress and fluoxetine-induced secretion of corticosterone and progesterone. J Pharmacol Exp Ther 295 (1998) 579-587
23. Goodnick P.J., and Goldstein B.J. Selective serotonin reuptake inhibitors in affective disorders: I. Basic pharmacology. J Psychopharmacol 12 (1998) S5-S20
24. Holmes M.C., French K.L., and Seckl J.R. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Mol Brain Res 28 (1995) 186-192
25. Joels M., and De Kloet E.R. Coordinative mineralocorticoid and glucocorticoid receptor-mediated control of responses to serotonin in rat hippocampus. Neuroendocrinology 55 (1992) 344-350
26. Jutkiewicz E.M., Wood S.K., Houshyar H., Hsin L.W., Rice K.C., and Woods J.H. The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology (Berl) 180 (2005) 215-223
27. Kirby L.G., Rice K.C., and Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacol 22 (2000) 148-162
28. Kulkarni S.K., and Dhir A. Effect of various classes of antidepressants in behavioral paradigms of despair. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1248-1254
29. Linthorst A.C., Flachskamm C., Hopkins S.J., Hoadley M.E., Labeur M.S., Holsboer F., et al. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J Neurosci 17 (1997) 4448-4460
30. Linthorst A.C., Penalva R.G., Flachskamm C., Holsboer F., and Reul J.M. Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism. Eur J Neurosci 16 (2002) 2441-2452
31. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8 (1997) 523-532
32. MacSweeney C.P., Lesourd M., and Gandon J.M. Antidepressant-like effects of alnespirone (S 20499) in the learned helplessness test in rats. Eur J Pharmacol 345 (1998) 133-137
33. McKenna M.T., Michaud C.M., Murray C.J., and Marks J.S. Assessing the burden of disease in the United States using disability-adjusted life years. Am J Prev Med 28 (2005) 415-423
34. Millan M.J. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. Eur J Pharmacol 500 (2004) 371-384
35. 1A receptors, and imipramine have similar activity in a chronic mild stress model of depression. Pharmacol Biochem Behav 63 (1999) 647-653
36. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
37. Nestler E.J. Antidepressant treatments in the 21st century. Biol Psychiatry 44 (1998) 526-533
38. Nikisch G., Mathe A.A., Czernik A., Thiele J., Bohner J., Eap C.B., et al. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology (Berl) 181 (2005) 751-760
39. Roth B.L. Multiple serotonin receptors: clinical and experimental aspects. Ann Clin Psychiatry 6 (1994) 67-78
40. Pandey G.N., Sharma R.P., Janicak P.G., and Davis J.M. Monoamine oxidase and cortisol response in depression and schizophrenia. Psychiatry Res 44 (1992) 1-8
41. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
42. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47 (1978) 379-391
43. Price M.L., and Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci 21 (2001) 2833-2841
44. Price L.H., Charney D.S., and Heninger G.R. Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects. Psychopharmacology (Berl) 92 (1987) 431-437
45. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., and Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacol 18 (1998) 492-502
46. Price M.L., Kirby L.G., Valentino R.J., and Lucki I. Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Psychopharmacology (Berl) 162 (2002) 406-414
47. Qiao C.F., Han Q.B., Mo S.F., Song J.Z., Xu L.J., Chen S.L., et al. Psoralenoside and isopsoralenoside, two new benzofuran glycosides from Psoralea corylifolia. Chem Pharm Bull (Tokyo) 54 (2006) 714-716
48. Renard C.E., Fiocco A.J., Clenet F., Hascoet M., and Bourin M. Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?. Psychopharmacology (Berl) 159 (2001) 42-50
49. Reneric J.P., and Lucki I. Antidepressant behavioral effects by dual monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl) 136 (1998) 190-197
50. Risbrough V.B., and Stein M.B. Role of corticotropin releasing factor in anxiety disorder: a translational research perspective. Horm Behav 50 (2006) 550-561
51. Semont A., Fache M., Ouafik L., Hery M., Faudon M., and Hery F. Effect of serotonin inhibition on glucocorticoid and mineralocorticoid expression in various brain structures. Neuroendocrinology 69 (1999) 121-128
52. Siuciak J.A., and Fujiwara R.A. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors. Psychopharmacology (Berl) 175 (2004) 163-169
53. Smialowska M., Bajkowska M., Heilig M., Obuchowicz E., Turchan J., Maj M., et al. Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala. Neuropeptides 35 (2001) 82-91
54. Tyrka A.R., Mello A.F., Mello M.F., Gagne G.G., Grover K.E., Anderson G.M., et al. Temperament and hypothalamic-pituitary-adrenal axis function in healthy adults. Psychoneuroendocrinology 31 (2006) 1036-1045
55. Welch A.S., and Welch B.L. Solvent extraction method for simultaneous determination of norepinephrine, dopamine, serotonin, and 5-hydroxyindoleacetic acid in a single mouse brain. Anal Biochem 30 (1969) 161-179
56. Willner P. The validity of animal models of depression. Psychopharmacology (Berl) 83 (1984) 1-16
57. Yang Y.M., Hyun J.W., Sung M.S., Chung H.S., Kim B.K., Paik W.H., et al. The cytotoxicity of psoralidin from Psoralea corylifolia. Planta Med 62 (1996) 353-354